Tanguler Tolga

EVP, Chief Commercial OfficerALNYLAM PHARMACEUTICALS, INC. (ALNY) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$746K
Net Open-Market Flow
-$746K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)289$321.82$93K36K
Mar 4, 2026Sell(S)215$320.81$69K36K
Mar 4, 2026Sell(S)102$320.01$33K36K
Mar 4, 2026Sell(S)767$323.84$248K35K
Mar 4, 2026Sell(S)272$324.88$88K35K
Mar 4, 2026Sell(S)350$323.01$113K36K
Mar 4, 2026Sell(S)106$319.03$34K37K
Mar 4, 2026Sell(S)208$325.67$68K34K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001735276-26-000060) within minutes of acceptance. Every field above traces to the original document. Verify it directly: